Patent · US Active

E. coli BL21 strain lacking a functional group II capsular gene cluster

US8535909B2 · kind B2 · utility

12Cited by

0References

14Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Helle Fabricius Woldike · Avenue Madeleine, DK
Jianhui DENG · Chengdu, CN
Xin Zhao · Austin, US
Yun Liu · Beijing, CN
Jing Su · Scotch Plains, US

Key dates

Filing date	Nov 10, 2009
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Feb 2, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/70
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a novel non-pathogenic Escherichia coli (E. coli) B BL21 strain comprising a deletion of group II capsular gene cluster, and the use thereof for the production of peptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.